Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02978547
Title The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma (Metformin 001)
Acronym Metformin 001
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.